Plain-English translation of NCT07441889 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new approach called , which uses your own immune cells to fight advanced breast or prostate cancer. Doctors collect your white blood cells, coat them with a special antibody to activate them, and then return them to your body so they can multiply and attack cancer cells. The goal is to see whether this personalized immune treatment can help patients whose cancer has progressed despite other treatments.
Advanced breast and prostate cancers often become resistant to standard treatments, leaving patients with limited options. This trial exists to test whether arming your own immune system with this medication offers a new way to fight these cancers.
You likely qualify if…
You likely don't qualify if…
You will have a procedure to collect your white blood cells (called leukapheresis), which takes a few hours. After at least 72 hours, you'll begin receiving infusions of your prepared cells—five infusions given weekly, then four more given every other week. Throughout the trial, you'll have regular blood tests and imaging scans to monitor your cancer and immune response. After your initial five infusions, you'll have another cell collection procedure. The full treatment course will span several months, with ongoing follow-up visits.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States